$IONS

AI 分析

生成於 May 11, 2026

AI Score
52/ 100
Hold$IONS

Ionis Pharmaceuticals

$IONSNASDAQHealthcareMid-Cap

Ionis pioneers antisense technology to develop RNA-targeted therapeutics for serious diseases.

Market Cap
$7.0B
Revenue (TTM)
$0.8B
+5.0%
Net Income (TTM)
-$0.3B
N/A
EPS (TTM)
-$2.00
P/E Ratio
N/A
Dividend Yield
0.0%
52-Week Range
$38-$55
Beta
0.62
Dimension Scores
Fundamental
45
Technical
50
Sentiment
58
Risk / Reward
48
Momentum
58
FundTechSentRiskMome
Financial Health
Profitability
50weak
Growth
61moderate
Liquidity
56strong
Solvency
47moderate
Efficiency
43moderate

Valuation, technical analysis, investment thesis, risk assessment and more for $IONS

Free · No credit card required

免責聲明: AI 生成的分析僅供教育參考,不構成投資建議。請始終諮詢合格的理財顧問。

探索更多

用 AI 分析任意股票

獲取涵蓋基本面、技術面、情緒面、風險評估和投資論點的結構化研究報告——約 60 秒完成。